Filters
reset allOther countries
Results: 1 to 15 of 15
Tests names and labs | Conditions | Genes, analytes, and microbes | Methods |
---|---|---|---|
TYRP1 - NGS including CNV analysis Centogene AG - the Rare Disease Company Germany | 2 | 1 |
|
Centogene AG - the Rare Disease Company Germany | 417 | 413 |
|
Centogene AG - the Rare Disease Company Germany | 157 | 151 |
|
Invitae Oculocutaneous Albinism Panel Invitae United States | 28 | 22 |
|
Invitae Hypopigmentation Panel Invitae United States | 83 | 46 |
|
Invitae Inherited Retinal Disorders Panel Invitae United States | 486 | 293 |
|
Invitae Comprehensive Carrier Screen Invitae United States | 886 | 547 |
|
PreventionGenetics United States | 39 | 33 |
|
Oculocutaneous Albinism Type 3 (OCAIII) via the TYRP1 Gene PreventionGenetics United States | 1 | 1 |
|
Oculocutaneous Albinism (OCA) Panel PreventionGenetics United States | 18 | 15 |
|
Baylor Genetics United States | 842 | 637 |
|
Laboratorio de Genetica Clinica SL Spain | 6 | 6 |
|
Fulgent Genetics United States | 2 | 1 |
|
Fulgent Genetics United States | 5129 | 4672 |
|
Fulgent Genetics United States | 52 | 28 |
|
Results: 1 to 15 of 15
IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.